TOT BIOPHARM International Company Limited
Equities
1875
HK0000545266
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 HKD | -2.27% |
|
-4.44% | +9.14% |
15/03 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.14% | 22Cr | |
+16.13% | 12TCr | |
+19.65% | 11TCr | |
+21.22% | 2.65TCr | |
-23.84% | 1.94TCr | |
-17.47% | 1.62TCr | |
-45.95% | 1.52TCr | |
-19.28% | 1.54TCr | |
+63.81% | 1.49TCr | |
+1.94% | 1.35TCr |
- Stock Market
- Equities
- 1875 Stock
- News TOT BIOPHARM International Company Limited
- TOT Biopharm Arm Engages MCC Unit to Construct Global R&D Center in Chinese Province